Daily BriefsIndia

Daily Brief India: Ola Electric, Religare Enterprises, Excel Industries, Dr Agarwal’s Health Care Ltd and more

In today’s briefing:

  • Ola Electric IPO Lockup – US$1.6bn+ Lockup Release
  • The Religare Controversy: A Corporate Battle
  • The Beat Ideas: Excel Industries Ltd
  • Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage


Ola Electric IPO Lockup – US$1.6bn+ Lockup Release

By Sumeet Singh

  • Ola Electric (OLAELEC IN) raised around US$734m in its India IPO in August 2024. The lockup for its pre-IPO investors is set to expire soon.
  • Ola Electric Mobility is a vertically integrated pure EV player in India with manufacturing capabilities for EVs and EV components, including cells
  • In this note, we will talk about the lockup dynamics and possible placement.

The Religare Controversy: A Corporate Battle

By Nimish Maheshwari

  • Religare Enterprises (RELG IN)’s saga intensifies as CEO Rashmi Saluja sues her own company amid takeover bids by the Burman family, amid insider trading allegations.
  • The battle, initially a takeover bid, has evolved into an ED probe, halting shareholder meetings and raising serious governance concerns.
  • Everything lies in the hands of Religare’s shareholder since to gain the helm again Rashmi needs more than 50% votes in the upcoming meeting on 7-Feb.

The Beat Ideas: Excel Industries Ltd

By Sudarshan Bhandari

  • Excel Industries (EXL IN) faced severe financial declines in FY24 but showed early Q2 FY25 improvement through higher export revenues and better margins amid strategic capacity expansion and new partnerships.
  • Its diversified product portfolio, especially DETC, and proactive R&D investments are key to overcoming volatility, making Excel Industries pivotal in sustaining India’s chemical innovation despite market headwinds.
  • Investors should note that despite recent downturns, targeted expansion and strategic partnerships could reverse performance trends, revealing potential long-term value if operational challenges are resolved.

Dr Agarwal’s Healthcare IPO Trading – Decent Anchor Demand but Subdued Overall Coverage

By Akshat Shah

  • Dr Agarwal’s Health Care Ltd (8140044Z IN) raised around US$350m in its India IPO.
  • Dr Agarwal’s Health Care is a healthcare/hospital chain in India providing eyecare services, including surgeries; consultations, diagnoses, non-surgical treatments; and sells opticals, contact lens, accessories and eyecare related pharmaceutical products.
  • We have looked at the company’s past performance and valuations in our previous notes. In this note, we will talk about the trading dynamics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars